Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma

Nature Cell Biology

Volumn 16, Issue 5, 2014, Pages 469-478

  Shin, Kunyoo ^a   Lim, Agnes ^a   Odegaard, Justin I ^a   Honeycutt, Jared D ^a   Kawano, Sally ^a   Hsieh, Michael H ^a   Beachy, Philip A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CANCER CELL; CARCINOMA IN SITU; CELL LINEAGE; CELL LOSS; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; INVASIVE CARCINOMA; MALE; MOUSE; MUSCLE INVASIVE BLADDER CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; STEM CELL; TISSUE DISTRIBUTION; UROTHELIUM; ANIMAL CELL; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; GENE EXPRESSION; HUMAN; SHH GENE;

ERINACEIDAE;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOMA; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENOTYPE; HEDGEHOG PROTEINS; HUMANS; MALE; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PHENOTYPE; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TUMOR BURDEN; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84899953445     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2956     Document Type: Article

References (57)

1. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
2. Taipale, J. & Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354 (2001).
3. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997).
4. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
5. Blanpain, C. Tracing the cellular origin of cancer. Nat. Cell Biol. 15, 126-134 (2013).
6. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
7. Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730-735 (2012).
8. Flesken-Nikitin, A. et al. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495, 241-245 (2013).
9. Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526 (2012).
10. Driessens, G., Beck, B., Caauwe, A., Simons, B. D. & Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 488, 527-530 (2012).
11. Molyneux, G. et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
12. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913 (2009).
13. Lawson, D. A. et al. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc. Natl Acad. Sci. USA 107, 2610-2615 (2010).
14. Mulholland, D. J. et al. Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res. 69, 8555-8562 (2009).
15. Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P. & Witte, O. N. Identification of a cell of origin for human prostate cancer. Science 329, 568-571 (2010).
16. Wang, X. et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495-500 (2009).
17. Wang, Z. A. et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell Biol. 15, 274-283 (2013).
18. Miyamoto, T., Weissman, I. L. & Akashi, K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl Acad. Sci. USA 97, 7521-7526 (2000).
19. Shin, K. et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110-114 (2011).
20. Nagao, M., Suzuki, E., Yasuo, K., Yahagi, T. & Seino, Y. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds. Cancer Res. 37, 399-407 (1977).
21. Bryan, G. T. The pathogenesis of experimental bladder cancer. Cancer Res. 37, 2813-2816 (1977).
22. Hecht, S. S. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch. Surg. 391, 603-613 (2006).
23. Zeegers, M. P., Tan, F. E., Dorant, E. & van Den Brandt, P. A. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89, 630-639 (2000).
24. Bryan, G. T. Pathogenesis of human urinary bladder cancer. Environ. Health Perspect. 49, 201-207 (1983).
25. Spruck, C. H., 3rd et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 54, 784-788 (1994).
26. Chan, K. S. et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl Acad. Sci. USA 106, 14016-14021 (2009).
27. He, X. et al. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 27, 1487-1495 (2009).
28. Yamaizumi, M., Mekada, E., Uchida, T. & Okada, Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15, 245-250 (1978).
29. Maxwell, F., Maxwell, I. H. & Glode, L. M. Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain. Mol. Cell. Biol. 7, 1576-1579 (1987).
30. Wu, S., Wu, Y. & Capecchi, M. R. Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development 133, 581-590 (2006).
31. Jost, S. P. Cell cycle of normal bladder urothelium in developing and adult mice. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 57, 27-36 (1989).
32. Thievessen, I., Wolter, M., Prior, A., Seifert, H. H. & Schulz, W. A. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. J. Cell. Physiol. 203, 372-377 (2005).
33. Kimura, F. et al. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int. J. Cancer [J. International du Cancer] 104, 568-578 (2003).
34. Sidransky, D. et al. Clonal origin bladder cancer. N. Engl. J. Med. 326, 737-740 (1992).
35. Simon, R. et al. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res. 61, 355-362 (2001).
36. Fadl-Elmula, I. et al. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding. British J. Cancer 81, 6-12 (1999).
37. Yamamoto, S., Tatematsu, M., Yamamoto, M., Fukami, H. & Fukushima, S. Clonal analysis of urothelial carcinomas in C3H/HeNBALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 19, 855-860 (1998).
38. Hafner, C. et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20, 4910-4915 (2001).
39. Trkova, M. et al. Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer. Cancer Lett. 242, 68-76 (2006).
40. Duggan, B. J. et al. Oligoclonality in bladder cancer: the implication for molecular therapies. J. Urol. 171, 419-425 (2004).
41. Dahse, R., Gartner, D., Werner, W., Schubert, J. & Junker, K. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences. Oncol. Rep. 10, 2033-2037 (2003).
42. Paiss, T. et al. Some tumors of the bladder are polyclonal in origin. J. Urol. 167, 718-723 (2002).
43. Vriesema, J. L., Aben, K. K., Witjes, J. A., Kiemeney, L. A. & Schalken, J. A. Superficial and metachronous invasive bladder carcinomas are clonally related. Int. J. Cancer 93, 699-702 (2001).
44. Rinkevich, Y., Lindau, P., Ueno, H., Longaker, M. T. & Weissman, I. L. Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip. Nature 476, 409-413 (2011).
45. Hisha, H. et al. Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells. Sci. Rep. 3, 3224 (2013).
46. Yanai, H., Tanaka, T. & Ueno, H. Multicolor lineage tracing methods and intestinal tumors. J. Gastroenterol. 48, 423-433 (2013).
47. Montironi, R., Mazzucchelli, R., Lopez-Beltran, A., Cheng, L. & Scarpelli, M. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat. Clin. Practice Urol. 4, 321-332 (2007).
48. Ayala, A. G. & Ro, J. Y. Prostatic intraepithelial neoplasia: recent advances. Arch. Pathol. Lab Med. 131, 1257-1266 (2007).
49. Scarlett, C. J., Salisbury, E. L., Biankin, A. V. & Kench, J. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology 43, 183-200 (2011).
50. Maitra, A., Fukushima, N., Takaori, K. & Hruban, R. H. Precursors to invasive pancreatic cancer. Adv. Anat. Pathol. 12, 81-91 (2005).
51. Allred, D. C. Ductal carcinoma in situ: terminology, classification, and natural history. J. Natl Cancer Inst. Monogr. 2010, 134-138 (2010).
52. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
53. Hoglund, M. Bladder cancer, a two phased disease? Semin. Cancer Biol. 17, 225-232 (2007).
54. Cheng, L. et al. Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer 94, 104-110 (2002).
55. Slaughter, D. P., Southwick, H. W. & Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6, 963-968 (1953).
56. Forsti, A., Louhelainen, J., Soderberg, M., Wijkstrom, H. & Hemminki, K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur. J. Cancer 37, 1372-1380 (2001).
57. Prevo, L. J., Sanchez, C. A., Galipeau, P. C. & Reid, B. J. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res. 59, 4784-4787 (1999).